Therapy News and Research

RSS

Study uncovers how certain E. coli bacteria in the gut promote colon cancer

Scientists have uncovered how certain E. coli bacteria in the gut promote colon cancer by binding to intestinal cells and releasing a DNA-damaging toxin.

6 Nov 2024

Gene editing with CRISPR may introduce new defects

The CRISPR tool is capable of repairing the genetic defect responsible for the immune disease chronic granulomatous disease.

6 Nov 2024

AI-powered MRI predicts outcomes in prostate cancer

Researchers determine whether artificial intelligence-based MRI data could predict prostate cancer patient outcomes.

6 Nov 2024

Targeted bacteriophages offer standardized and scalable GI therapy

In a new study, researchers at the University of Copenhagen have been cultivating 'good viruses' from feces. The goal is to replace fecal capsules now being used in so-called fecal transplants. Their new technique has shown potential in studies with mice and the hope is that it will improve this life-saving treatment through standardization and pave its way toward mainstream medicine.

5 Nov 2024

Study reveals low rates of palliative care for heart failure patients in the U.S.

A study by researchers at Saint Louis University shows that only one in eight patients with heart failure in the United States receive palliative care consultations within five years of diagnosis.

5 Nov 2024

Innovative heart model could transform personalized cardiac therapy

A team led by researchers at UNC-Chapel Hill have developed an innovative computer model of blood flow in the human heart that promises to transform how we understand, diagnose, and treat heart conditions.

5 Nov 2024

Consortium receives 10 million euros to study in vivo tissue mechanics

The European Research Council is funding a consortium consisting of the Helmholtz-Zentrum Hereon, ETH Zurich and TU Graz with a total of 10 million euros for developing new methods to determine the mechanical properties of living human tissue.

5 Nov 2024

Multi-omics-based classification of gastrointestinal stromal tumors lays groundwork for precision treatment

A recent study offering a comprehensive view of the genome and transcriptome of gastrointestinal stromal tumors (GISTs) has introduced a new, multi-omics-based molecular classification of these tumors.

5 Nov 2024

Curcumin compound reactivates Epstein–Barr virus, offering safer cancer therapy

A novel curcumin derivative, C210, activates the Epstein–Barr virus (EBV) lytic cycle without producing infectious virions by disrupting HSP90. This discovery opens avenues for safer EBV-positive cancer therapies.

5 Nov 2024

Researchers awarded Synergy Grant to target tumor vessels and boost immunotherapy

Targeting and customizing blood vessels in tumors to increase T cell infiltration and maintain their function may represent the next breakthrough in cancer therapy.

5 Nov 2024

No evidence Trump’s drug program for terminal patients saved ‘thousands’ of lives

Former President Donald Trump has boasted in recent months about "Right To Try," a law he signed in 2018. It's aimed at boosting terminally ill patients' access to potentially lifesaving medications not yet approved by the Food and Drug Administration.

5 Nov 2024

A quick return to school and light exercise may help kids recover from concussions

During cheerleading practice in April, Jana Duey's sixth grade daughter, Karter, sustained a concussion when she fell several feet headfirst onto a gym floor mat. Days after, Karter still had a headache, dizziness, and sensitivity to light and noise.

5 Nov 2024

Modulating CD39 expression to enhance CAR-T cell therapy against hepatocellular carcinoma

In the quest to enhance the efficacy of chimeric antigen receptor T (CAR-T) cell therapy against hepatocellular carcinoma (HCC), a recent study has identified a pivotal role for CD39 expression in modulating the function of CAR-T cells.

5 Nov 2024

Lupus Research Alliance announces 33 studies to be presented at ACR Convergence 2024

The Lupus Research Alliance (LRA), the largest private funder of lupus research worldwide, today announced that a total of 33 studies, funded by the organization or supported by its clinical research affiliate Lupus Therapeutics, will be presented at ACR Convergence 2024.

5 Nov 2024

Johns Hopkins study offers new hope for wet AMD patients

A new study from researchers at Wilmer Eye Institute, Johns Hopkins Medicine explains not only why some patients with wet age-related macular degeneration (or "wet" AMD) fail to have vision improvement with treatment, but also how an experimental drug could be used with existing wet AMD treatments to save vision.

4 Nov 2024

Therapy News and Research

Study uncovers how certain E. coli bacteria in the gut promote colon cancer

Gene editing with CRISPR may introduce new defects

AI-powered MRI predicts outcomes in prostate cancer

Targeted bacteriophages offer standardized and scalable GI therapy

Study reveals low rates of palliative care for heart failure patients in the U.S.

Innovative heart model could transform personalized cardiac therapy

Consortium receives 10 million euros to study in vivo tissue mechanics

Multi-omics-based classification of gastrointestinal stromal tumors lays groundwork for precision treatment

Curcumin compound reactivates Epstein–Barr virus, offering safer cancer therapy

Researchers awarded Synergy Grant to target tumor vessels and boost immunotherapy

No evidence Trump’s drug program for terminal patients saved ‘thousands’ of lives

A quick return to school and light exercise may help kids recover from concussions

Modulating CD39 expression to enhance CAR-T cell therapy against hepatocellular carcinoma

Lupus Research Alliance announces 33 studies to be presented at ACR Convergence 2024

Johns Hopkins study offers new hope for wet AMD patients

New targets identified for treating glioblastoma through genetic screen

New insights into early Huntington's disease mechanisms

$1 million grant supports research on groundbreaking therapies for MS

Researchers develop the first polymer-based therapeutic for Huntington’s disease

Mortality risk higher for those diagnosed with type 2 diabetes at younger ages

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News